Masivo Highlights Wide Historic High-Grade Results from Cerro Colorado and Announces Equity RaiseJune 27, 2025 11:30 AM EDT | Source: Masivo Silver Corp.Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") is pleased to report encouraging historic results from the two known drill holes completed at the drill target for Cerro Colorado Gold-Silver Project in Sonora, Mexico, as the Company advances final due ...

Investors might want to bet on 908 Devices Inc. (MASS) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual inves ...

Strategic Transformation Realized MARCH 5th 2025 designed for 'point-of-need' use in vital health and safety contexts Forward looking statements / Non-GAAP financial measures This presentation and the accompanying oral presentation (this "presentation") contain forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements may relate to, but are not limited to, expectations ...

Lastly, this presentation incudes certain financial measures not prepared in accordance with generally accepted accounting principles ("GAAP"), including adjusted gross profit, adjusted gross margin percentage and adjusted EBITDA. These non-GAAP financial measures should be considered as a supplement to and not a substitute for GAAP financial measures. Reconciliations to the most directly comparable GAAP financial measures can be found in this presentation. 2 Analysis at the speed of life MAY 2025 Forward l ...

908 Devices (MASS) FY Conference June 04, 2025 05:00 PM ET Speaker0 For the nine zero eight devices management presentation. My name is Matt Larue. I cover, tools, including nine zero eight here at Blair. Two quick announcements, before we get to the presentation. Breakout session is in Burnham B on the Second Floor. And then for complete business disclosures, please, visit WilliamBlair.com. Very pleased to have, one of the cofounder and CEO, doctor Kevin Knopf here, as well as CFO, Joe Griffith, who've joi ...

公司动态 - 908 Devices股价本周上涨超过18% [1] - 公司与罗马尼亚海关达成交易，提供27台MX908设备 [2] - MX908设备具有快速化学分析能力，可在几秒钟内识别多种化学物质 [4] - 所有设备已于今年早些时候交付 [5] - 交易通过欧盟海关控制设备计划完成 [5] 产品与技术 - MX908是手持式化学分析设备，可检测车辆外部和容器表面的微量化合物 [4] - 设备能够提供快速、痕量化学物质识别能力 [6] 市场影响 - 与政府机构交易有助于提升公司声誉并吸引新客户 [7] - 投资者对公司与罗马尼亚海关的交易反应积极 [8] 管理层观点 - CEO Kevin Knopp表示罗马尼亚海关采取积极措施提升边境安全 [6] - 公司承诺支持罗马尼亚海关加强边境安全和安保工作 [6]

公司评级升级 - 908 Devices Inc (MASS) 近期被上调至Zacks Rank 2(买入评级) 因盈利预估上升趋势触发了评级变化 [1] - Zacks评级核心依据是公司盈利前景变化 跟踪卖方分析师对当前及未来年度EPS共识预期(Zacks Consensus Estimate) [1] - 评级上调反映市场对其盈利前景的乐观预期 可能转化为买入压力并推高股价 [3] 盈利预估与股价关系 - 盈利预估修正与短期股价波动存在强相关性 机构投资者通过盈利预估计算股票公允价值并据此交易 [4] - 实证研究表明跟踪盈利预估修正趋势可有效指导投资决策 Zacks评级系统通过四类盈利相关因素将股票分为五档 [6] - Zacks Rank 1(强力买入)股票自1988年以来年均回报率达+25% 评级系统覆盖4000余只股票中仅前5%获此评级 [7][9] 908 Devices盈利修正详情 - 2025财年预计每股亏损0.62美元 较上年同期改善54.1% [8] - 过去三个月Zacks共识预期上调51.8% 分析师持续调高盈利预测 [8] - 当前评级位列Zacks覆盖股票前20% 显示其盈利修正优势 有望产生超额回报 [10]

908 Devices (MASS) Q1 2025 Earnings Call May 13, 2025 08:30 AM ET Company Participants Kelly Gura - Vice PresidentKevin Knopp - Co-Founder, CEO & DirectorJoseph Griffith - CFODaniel Arias - Managing DirectorPuneet Souda - Senior MD Conference Call Participants Matt Larew - Research Analyst - HealthcareBrendan Smith - Director & Senior Analyst Operator Hello, and welcome, everyone, to the nine zero eight Devices First Quarter twenty twenty five Financial Results Conference Call. My name is Becky, and I'll be ...

908 Devices (MASS) Q1 2025 Earnings Call May 13, 2025 08:30 AM ET Speaker0 Hello, and welcome, everyone, to the nine zero eight Devices First Quarter twenty twenty five Financial Results Conference Call. My name is Becky, and I'll be your operator today. I will now hand over to your host, Kelly Gura, Investor Relations, to begin. Please go ahead. Speaker1 Thank you. This morning, nine zero eight Devices released financial results for the first quarter ended 03/31/2025. If you've not received this news relea ...

公司业绩表现 - 908 Devices Inc (MASS) 2025年第一季度每股亏损0.22美元，低于Zacks共识预期的0.27美元亏损，同比去年同期的0.33美元亏损有所改善 [1] - 季度盈利超出预期18.52%，连续四个季度均超共识EPS预期 [1][2] - 季度营收1178万美元，低于共识预期2.99%，但较去年同期999万美元增长18% [2] 股价与市场表现 - 公司股价年初至今累计上涨160.5%，同期标普500指数下跌0.6% [3] - 当前Zacks评级为"强力买入"(Rank 1)，预计短期内将跑赢大盘 [6] 未来业绩展望 - 下季度共识预期为每股亏损0.18美元，营收1230万美元 [7] - 当前财年共识预期为每股亏损0.63美元，营收5548万美元 [7] - 盈利预测修正趋势向好，但需关注财报发布后预期调整情况 [6][7] 行业比较 - 所属医疗设备行业在Zacks行业排名中位列前31%，历史数据显示前50%行业表现优于后50%行业2倍以上 [8] - 同业公司Lucid Diagnostics (LUCD) 预计下季度每股亏损0.09美元，同比改善57.1%，营收预期130万美元(同比增长30%) [9][10]